A New Breakthrough in Immunotherapy?TCR Technology helps Treat Myeloma A clinical study showed that a new T cell receptor (TCR) therapy allowed 80% of patients with advanced myeloma to undergo a clinical response after autologous stem cell transplantation. The T cell receptor therapy used the human autoimmune system to Published 7 Years Ago by bellasmith
